These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28943959)

  • 1. Cyclin D1 overexpression correlates with poor tumor differentiation and prognosis in gastric cancer.
    Shan YS; Hsu HP; Lai MD; Hung YH; Wang CY; Yen MC; Chen YL
    Oncol Lett; 2017 Oct; 14(4):4517-4526. PubMed ID: 28943959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases.
    Takano Y; Kato Y; van Diest PJ; Masuda M; Mitomi H; Okayasu I
    Am J Pathol; 2000 Feb; 156(2):585-94. PubMed ID: 10666388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas and Paired Normal Mucosae Reveals Cyclin D1 Deregulation and Compensatory Effect of Cyclin D2.
    Novotný J; Bandúrová V; Strnad H; Chovanec M; Hradilová M; Šáchová J; Šteffl M; Grušanović J; Kodet R; Pačes V; Lacina L; Smetana K; Plzák J; Kolář M; Vomastek T
    Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32224897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Cyclin D1 gene in ovarian cancer and effect of silencing its expression on ovarian cancer cells based on the Oncomine database.
    Quan LL; Liu JY; Qu LX; La H; Wang HL; Chen XX; Wang N; Wei ZZ
    Bioengineered; 2021 Dec; 12(2):9290-9300. PubMed ID: 34806539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of argininosuccinate synthetase protein predicts poor prognosis in human gastric cancer.
    Shan YS; Hsu HP; Lai MD; Yen MC; Luo YP; Chen YL
    Oncol Rep; 2015 Jan; 33(1):49-57. PubMed ID: 25333458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma.
    Ortiz AB; Garcia D; Vicente Y; Palka M; Bellas C; Martin P
    PLoS One; 2017; 12(11):e0188068. PubMed ID: 29140993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1 overexpression in invasive breast cancers: correlation with cyclin-dependent kinase 4 and oestrogen receptor overexpression, and lack of correlation with mitotic activity.
    Takano Y; Takenaka H; Kato Y; Masuda M; Mikami T; Saegusa M; Okayasu I
    J Cancer Res Clin Oncol; 1999; 125(8-9):505-12. PubMed ID: 10480344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of cyclin D2/D3 in multiple human malignant neoplasms: A systematic review and meta-analysis.
    Ding ZY; Li R; Zhang QJ; Wang Y; Jiang Y; Meng QY; Xi QL; Wu GH
    Cancer Med; 2019 Jun; 8(6):2717-2729. PubMed ID: 30950241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of IC53d promotes the proliferation of gastric cancer cells by activating the AKT/GSK3β/cyclin D1 signaling pathway.
    Lin JX; Xie XS; Weng XF; Qiu SL; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Li P; Huang CM; Zheng CH
    Oncol Rep; 2019 May; 41(5):2739-2752. PubMed ID: 30864700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis.
    Takano Y; Kato Y; Masuda M; Ohshima Y; Okayasu I
    J Pathol; 1999 Oct; 189(2):194-200. PubMed ID: 10547574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of cyclin D1 overexpression on the prognosis of ER-positive breast cancers: a meta-analysis.
    Xu XL; Chen SZ; Chen W; Zheng WH; Xia XH; Yang HJ; Li B; Mao WM
    Breast Cancer Res Treat; 2013 Jun; 139(2):329-39. PubMed ID: 23670132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
    Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
    Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.
    Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
    Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent overexpression of cyclin D2/cyclin-dependent kinase 4 in Wilms' tumor.
    Faussillon M; Monnier L; Junien C; Jeanpierre C
    Cancer Lett; 2005 Apr; 221(1):67-75. PubMed ID: 15797629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of microRNA‑33a promotes cyclin‑dependent kinase 6, cyclin D1 and PIM1 expression and gastric cancer cell proliferation.
    Wang Y; Zhou X; Shan B; Han J; Wang F; Fan X; Lv Y; Chang L; Liu W
    Mol Med Rep; 2015 Nov; 12(5):6491-500. PubMed ID: 26352175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-transcriptional Modifications Contribute to the Upregulation of Cyclin D2 in Multiple Myeloma.
    Misiewicz-Krzeminska I; Sarasquete ME; Vicente-Dueñas C; Krzeminski P; Wiktorska K; Corchete LA; Quwaider D; Rojas EA; Corral R; Martín AA; Escalante F; Bárez A; García JL; Sánchez-García I; García-Sanz R; San Miguel JF; Gutiérrez NC
    Clin Cancer Res; 2016 Jan; 22(1):207-17. PubMed ID: 26341922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated nuclear CCND1 expression confers an unfavorable prognosis for early stage lung adenocarcinoma patients.
    Xu P; Zhao M; Liu Z; Liu Y; Chen Y; Luo R; Fang W
    Int J Clin Exp Pathol; 2015; 8(12):15887-94. PubMed ID: 26884860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study on the prognostic value of cyclins D1 and E expression levels in resectable gastric cancer and on some correlations between cyclins expression, histoclinical parameters and selected protein products of cell-cycle regulatory genes.
    Tenderenda M
    J Exp Clin Cancer Res; 2005 Sep; 24(3):405-14. PubMed ID: 16270527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence and prognostic value of HER2 overexpression and cyclin D1 expression in patients with gastric or gastroesophageal junction adenocarcinoma in Israel.
    Bar-Sela G; Hershkovitz D; Haim N; Kaidar-Person O; Shulman K; Ben-Izhak O
    Oncol Lett; 2013 Feb; 5(2):559-563. PubMed ID: 23420289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Cyclin D1 and CD44 Expression in Gastric Adenocarcinoma.
    Ibrahim HM; AbdElbary AM; Mohamed SY; Elwan A; Abdelhamid MI; Ibrahim A
    J Gastrointest Cancer; 2019 Sep; 50(3):370-379. PubMed ID: 29497929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.